Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19
With the number of COVID-19 cases rising globally, Bioquell, an Ecolab solution, is offering a proven solution to help eradicate COVID-19 in a range of healthcare, life sciences and pharmaceutical environments, such as isolation rooms and public spaces.
Utilising the company’s scientifically proven 35% Hydrogen Peroxide Vapour technology, Bioquell’s Rapid Bio-decontamination Service (RBDS) is helping to provide microbiologically clean surfaces and spaces for patients and staff.
Surface contamination has been implicated in the transmission of certain viruses, including COVID-19, and surface decontamination is an effective measure to interrupt the spread of these agents.
Bioquell’s Hydrogen Peroxide Vapour
A study on the virucidal efficacy of Bioquell’s Hydrogen Peroxide Vapour was published in the April 2014 issue of The Journal of Hospital Infection. The study evaluated the in-vitro efficacy of Bioquell Hydrogen Peroxide Vapour for the in-activation of a number of structurally distinct viruses that could impact the healthcare, veterinary and public sectors, including feline calicivirus (FCV); human adenovirus type 1; transmissible gastroenteritis COVID-19 of pigs (TGEV): a severe acute respiratory syndrome COVID-19 (SARS-CoV surrogate); avian influenza virus (AIV); and swine influenza virus (SwIV).
The findings showed that after exposure to Bioquell’s Hydrogen Peroxide Vapour, no viable viruses were identified.
The technology also has been evaluated by the UK Government’s Biosafety Group at the Centre for Emergency Preparedness and Response, Porton Down, using the non-enveloped virus surrogate MS2 phage, with full inactivation achieved.
Cleaning and disinfection
Respiratory viruses can contaminate and survive for long periods on environmental surfaces. Effective disinfection is essential for stopping transmission from the environment. However, this is not always achieved by conventional cleaning and disinfection techniques.
Bioquell’s Hydrogen Peroxide Vapour is a vapour-phase disinfection method that is virucidal on structurally distinct viruses dried on surfaces.
It achieves a level of efficacy unmatched by standard cleaning practices and other disinfection technologies. It is uniform across the entire target area and not limited to line-of-sight or easy-to-reach spaces.
Eradicate COVID-19 via bio-decontamination
Bioquell’s RBDS can be quickly called upon to eradicate COVID-19 from a single area, several locations within a facility or an entire building. Using Bioquell’s 35% Hydrogen Peroxide Vapour solution (Bioquell HPV-AQ,) it can eliminate pathogens, providing a 6-log sporicidal kill.
Through complete coverage of every exposed surface in an enclosed area, the process is residue-free, proven safe on sensitive electronics and shown to kill a wide range of microorganisms including bacteria, viruses, fungi, spores and more.
Bioquell’s RBDS offers the flexibility to retain or recover the microbial integrity of critical areas with every deployment including planning, coordination, setup, equipment, and cycle validation and verification. It provides a complete final report confirming a 6-log kill of the spaces and surfaces that have been treated with the use of biological and chemical indicators.
For further information on Bioquell’s RBDS click here.
Bioquell, an Ecolab solution, is a well-established global leader providing validated and compliant surface and airborne bio-decontamination with 35% Hydrogen Peroxide Vapour for the pharmaceutical, life science and healthcare sectors. With its head office located in Andover in the UK, the company operates worldwide through its own sales offices and international distributor network.
Bioquell’s Hydrogen Peroxide Vapour decontamination technology is used globally to eradicate biological contaminants including problematic bacteria, viruses and fungi on every exposed surface in any suitable enclosure to ensure maximum uptime. It provides residue-free, safe and repeatable disinfection of rooms, buildings, equipment and sensitive electronics.
A trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and energy technologies and services that protect people and vital resources, including bio-decontamination. With annual sales of $15 billion and 49,000 associates, Ecolab delivers comprehensive solutions, data-driven insights and on-site service to promote safe food, maintain clean environments, optimise water and energy use, and improve operational efficiencies for customers in the food, healthcare, energy, hospitality and industrial markets in more than 170 countries around the world. For more Ecolab news and information, visit www.ecolab.com.
S.M. Goyal, Y. Chander, S. Yezli , J.A. Otter. 2014. Evaluating the virucidal efficacy of hydrogen peroxide vapour. J. Hosp. Infec. Vol 86, 255-259. S.M. Goyal a, *, Y. Chander a, S. Yezli b, J.A. Otter
T. Pottage, C. Richardson, S. Parks, J.T. Walker, A.M. Bennett. 2009. Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses. J. Hosp. Infect.doi:10. 1016/j.jhin.2009.08.020
Van Doremalen et al. 2020. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. US Government work. medRxiv preprint doi: 10.1101/2020.03.09.20033217
*Please note: This is a commercial profile